EurekAlert! -
11 May 2018 06:00
(Wiley) The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures.
Share this Article